Basic Information
| LncRNA/CircRNA Name | XLOC_124812 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | RNA-seq, qPCR etc. |
| Sample | HCC tissues, cell lines (HBXF344, SNU449, BEL7402, SMMC7721, HePG2, SK-Hep1, PLC/PRF/5, LM3, Hep3B, Huh7, LO2) |
| Expression Pattern | down-regulated |
| Function Description | Compared to normal liver tissue, the expression of Lnc-48 (XLOC_124812) was lost/reduced in HBXF344, SNU449, BEL7402, SMMC7721, HepG2, SK-Hep1, PLC/PRF/5, LM3, Huh7 and LO2 cells and increased in Hep3B cells. Reduced expression of Lnc-48 was found in 75% (9/12) of primary hepatic cancer. |
| Pubmed ID | 27115166 |
| Year | 2016 |
| Title | Systematic study of novel lncRNAs in different gastrointestinal cancer cells. |
External Links
| Links for XLOC_124812 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |